V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20210430 | 20154269 | 1.84 | 82.9 | Palliative (P) | 2016-07-07 | 2016-07-12 | GEMCITABINE + NAB PACLITAXEL | 02 | Y | GEMCITABINE + NAB-PACLITAXEL | 100998502 |
| 20210431 | 20154270 | 1.84 | 96.6 | Palliative (P) | 2020-11-08 | 2020-11-25 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100019435 |
| 20210433 | 20154271 | 1.65 | 66.4 | null | 2019-06-21 | 2019-07-10 | CAPECITABINE + CISPLATIN + Trastuzumab | null | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101615958 |
| 20210463 | 20154272 | 1.68 | null | Palliative (P) | 2022-03-23 | 2022-04-08 | GEMCITABINE + NAB PACLITAXEL | N | null | GEMCITABINE + NAB-PACLITAXEL | 101182649 |
| 20210466 | 20154273 | 1.56 | 66.4 | Palliative (P) | 2021-05-23 | 2021-06-14 | HCX | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101622541 |
| 20210474 | 20154274 | 1.72 | 73.1 | Palliative (P) | 2016-05-23 | 2016-05-31 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100268827 |
| 20210478 | 20154275 | 1.65 | 103.7 | 03 | 2017-09-08 | 2017-10-03 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 100316944 |
| 20210491 | 20154276 | 1.72 | 40 | Palliative (P) | 2019-02-09 | 2019-10-26 | ECX | N | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101225305 |
| 20210493 | 20154277 | 1.86 | 50 | Palliative (P) | null | 2021-04-30 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101759679 |
| 20210502 | 20154278 | 1.63 | 79.3 | Curative (C) | 2020-10-19 | 2020-10-22 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101268671 |
| 20210503 | 20154279 | 1.77 | 62.35 | 03 | 2019-04-02 | 2019-04-23 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101725928 |
| 20210504 | 20154280 | 1.58 | 65.1 | null | 2021-07-31 | 2021-08-18 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100560326 |
| 20210529 | 20154281 | 1.82 | 85.6 | Neo-adjuvant (N) | 2019-04-10 | 2019-04-10 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101223355 |
| 20210551 | 20154282 | 1.68 | 136 | Curative (C) | 2017-04-06 | 2017-04-21 | ECX | 02 | Y | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100584240 |
| 20210562 | 20154283 | 1.75 | 72.75 | Curative (C) | 2019-08-01 | 2019-10-03 | ECX | 02 | Y | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101311705 |
| 20210564 | 20154284 | 1.64 | 66.9 | null | 2021-01-12 | 2021-01-29 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100097038 |
| 20210580 | 20154285 | 1.8 | 68.3 | null | 2020-11-19 | 2020-12-03 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101011396 |
| 20210618 | 20154286 | 1.55 | 69.5 | Palliative (P) | null | 2016-10-17 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101660319 |
| 20210633 | 20154287 | 1.8 | 89 | Neo-adjuvant (N) | 2022-03-24 | 2022-03-25 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101323083 |
| 20210640 | 20154288 | 1.72 | 80.35 | Palliative (P) | 2017-10-05 | 2017-10-06 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101303690 |
| 20210651 | 20154289 | 1.59 | 72.5 | null | 2021-03-09 | 2021-03-21 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100340470 |
| 20210665 | 20154290 | 1.61 | 81 | Palliative (P) | null | 2021-03-28 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101832039 |
| 20210686 | 20154291 | 1.65 | 97.9 | Palliative (P) | 2019-05-05 | 2019-05-05 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100199083 |
| 20210707 | 20154292 | 1.72 | 59.8 | Neo-adjuvant (N) | 2019-09-11 | 2019-09-26 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100535174 |
| 20210709 | 20154293 | 1.58 | 82.6 | Palliative (P) | 2017-02-25 | 2017-03-22 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100267212 |
| 20210717 | 20154294 | 1.76 | 79.9 | Palliative (P) | 2016-06-28 | 2016-07-22 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101075756 |
| 20210722 | 20154295 | 1.8 | 80.1 | Palliative (P) | 2019-04-24 | 2019-05-13 | HCX | N | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101048774 |
| 20210724 | 20154296 | 1.77 | 57.3 | Palliative (P) | 2019-07-02 | 2019-07-20 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101843730 |
| 20210726 | 20154297 | 1.82 | 81 | Palliative (P) | 2019-12-07 | 2020-11-20 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101046629 |
| 20210731 | 20154298 | 1.5 | 40.5 | Palliative (P) | 2018-12-03 | 2018-12-03 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100427964 |
| 20210737 | 20154299 | 1.76 | 63.85 | Palliative (P) | null | 2020-01-09 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101648638 |
| 20210762 | 20154300 | 1.61 | 64.8 | Palliative (P) | 2018-03-19 | 2018-03-27 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101016908 |
| 20210769 | 20154301 | 1.87 | 80.9 | Palliative (P) | 2016-11-12 | 2016-11-14 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100790938 |
| 20210774 | 20154302 | 1.75 | 56.5 | Palliative (P) | 2019-05-03 | 2019-06-01 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100410147 |
| 20210782 | 20154303 | 1.72 | 55 | null | 2019-05-16 | 2019-11-18 | GEMCITABINE + NAB PACLITAXEL | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101092898 |
| 20210787 | 20154304 | 1.75 | 62.79 | Palliative (P) | 2022-01-09 | 2022-02-01 | CAPECITABINE + CARBOPLATIN | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100180458 |
| 20210800 | 20154305 | 1.75 | 66.1 | null | 2017-04-24 | 2017-05-07 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100506056 |
| 20210811 | 20154306 | 1.89 | 86.5 | Neo-adjuvant (N) | null | 2016-07-16 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100362822 |
| 20210814 | 20154307 | 1.76 | 131 | Palliative (P) | null | 2018-10-26 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100254617 |
| 20210821 | 20154308 | 1.84 | 103 | null | 2018-10-11 | 2018-10-11 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101226094 |
| 20210842 | 20154309 | 1.68 | 55.8 | Palliative (P) | null | 2018-10-17 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101157678 |
| 20210857 | 20154310 | 1.62 | 58.5 | Adjuvant (A) | 2017-10-31 | 2019-04-09 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100623249 |
| 20210879 | 20154311 | 1.59 | 78 | null | null | 2020-03-23 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100880388 |
| 20210895 | 20154312 | 1.5 | 107.5 | Palliative (P) | null | 2018-07-22 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101422268 |
| 20210898 | 20154313 | 1.63 | 75 | Palliative (P) | 2019-06-03 | 2019-06-24 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101528039 |
| 20210912 | 20154314 | 1.62 | 95.6 | null | 2019-12-31 | 2020-02-25 | Cape+Cisplatin+Trastuzumab Load | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101833695 |
| 20210926 | 20154315 | 1.66 | 80.6 | null | 2017-09-06 | 2017-12-03 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | CAPECITABINE + CARBOPLATIN | 100795957 |
| 20210930 | 20154316 | 1.8 | 76.3 | null | 2016-05-30 | 2016-06-29 | HCX (Cape + Cisp + Tras) - Load | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101413441 |
| 20210936 | 20154317 | 1.71 | 62.8 | Palliative (P) | 2019-04-05 | 2019-04-20 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100319216 |
| 20210938 | 20154318 | 1.56 | 72.3 | Palliative (P) | 2017-11-12 | 2018-03-15 | HCX | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101365603 |